Thurman M. Wheeler

2.8k total citations
19 papers, 2.2k citations indexed

About

Thurman M. Wheeler is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Thurman M. Wheeler has authored 19 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Thurman M. Wheeler's work include Genetic Neurodegenerative Diseases (17 papers), Muscle Physiology and Disorders (13 papers) and Mitochondrial Function and Pathology (8 papers). Thurman M. Wheeler is often cited by papers focused on Genetic Neurodegenerative Diseases (17 papers), Muscle Physiology and Disorders (13 papers) and Mitochondrial Function and Pathology (8 papers). Thurman M. Wheeler collaborates with scholars based in United States, Canada and France. Thurman M. Wheeler's co-authors include Charles A. Thornton, Maurice S. Swanson, Robert T. Dirksen, John D. Lueck, Krzysztof Sobczak, C. Frank Bennett, Sanjay K. Pandey, A. Robert MacLeod, Robert J. Osborne and Masayuki Nakamori and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Thurman M. Wheeler

19 papers receiving 2.1k citations

Peers

Countries citing papers authored by Thurman M. Wheeler

Since Specialization

Citations

This map shows the geographic impact of Thurman M. Wheeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thurman M. Wheeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thurman M. Wheeler more than expected).

Fields of papers citing papers by Thurman M. Wheeler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thurman M. Wheeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thurman M. Wheeler. The network helps show where Thurman M. Wheeler may publish in the future.

Co-authorship network of co-authors of Thurman M. Wheeler

This figure shows the co-authorship network connecting the top 25 collaborators of Thurman M. Wheeler. A scholar is included among the top collaborators of Thurman M. Wheeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thurman M. Wheeler. Thurman M. Wheeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy 2023 ·Nature Communications ·(unknown), (unknown), (unknown), Thurman M. Wheeler	5
2	Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy 2020 ·Molecular Therapy — Nucleic Acids ·(unknown), Eun Joo Kim, (unknown), Jia Li, Paloma González-Pérez, Seward B. Rutkove, Thurman M. Wheeler	18
3	Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies 2018 ·Nature Communications ·(unknown), (unknown), Leonora Balaj, Sudeshna Das, (unknown), Basil T. Darras, Tim W. Clark, Xandra O. Breakefield, Thurman M. Wheeler	36
4	Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1 2018 ·Nature Communications ·(unknown), (unknown), Timothy M. Baran, Soumya Mitra, C. Frank Bennett, Frank Rigo, Thomas H. Foster, Thurman M. Wheeler	20
5	Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice 2017 ·Molecular Therapy — Nucleic Acids ·Dominic Jauvin, (unknown), Sanjay K. Pandey, (unknown), (unknown), Guillaume Bassez, (unknown), A. Robert MacLeod, Geneviève Gourdon, Thurman M. Wheeler, Charles A. Thornton, C. Frank Bennett, Jack Puymirat	63
6	Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1 2015 ·Journal of Pharmacology and Experimental Therapeutics ·Sanjay K. Pandey, Thurman M. Wheeler, (unknown), Aneeza Kim, Husam S. Younis, Danielle Gattis, Dominic Jauvin, Jack Puymirat, Eric E. Swayze, Susan M. Freier, C. Frank Bennett, Charles A. Thornton, A. Robert MacLeod	93
7	Case 30-2015 2015 ·New England Journal of Medicine ·Thurman M. Wheeler, Joshua N. Baker, David A. Chad, (unknown), (unknown), Daniel A. Mordes	2
8	Splicing biomarkers of disease severity in myotonic dystrophy 2013 ·Annals of Neurology ·Masayuki Nakamori, Krzysztof Sobczak, Araya Puwanant, (unknown), Katy Eichinger, Shree Pandya, (unknown), Chad Heatwole, Michael McDermott, Tian Chen, Melissa Cline, Rabi Tawil, Robert J. Osborne, Thurman M. Wheeler, Maurice S. Swanson, Richard T. Moxley, Charles A. Thornton	188
9	Targeting nuclear RNA for in vivo correction of myotonic dystrophy 2012 ·Nature ·Thurman M. Wheeler, Andrew J. Leger, Sanjay K. Pandey, A. Robert MacLeod, Masayuki Nakamori, Seng H. Cheng, Bruce M. Wentworth, C. Frank Bennett, Charles A. Thornton	383
10	RNA Interference Targeting CUG Repeats in a Mouse Model of Myotonic Dystrophy 2012 ·Molecular Therapy ·Krzysztof Sobczak, Thurman M. Wheeler, Wenli Wang, Charles A. Thornton	72
11	Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy 2011 ·Neurobiology of Disease ·Ami Mankodi, Thurman M. Wheeler, (unknown), (unknown), Mark W. Bêcher, Charles A. Thornton	17
12	Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA 2009 ·Science ·Thurman M. Wheeler, Krzysztof Sobczak, John D. Lueck, Robert J. Osborne, Xiaoyan Lin, Robert T. Dirksen, Charles A. Thornton	303
13	Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy 2009 ·Proceedings of the National Academy of Sciences ·Susan Mulders, Walther J. A. A. van den Broek, Thurman M. Wheeler, Huib J. E. Croes, Petra van Kuik‐Romeijn, Sjef J. de Kimpe, Denis Furling, Gerard Platenburg, Geneviève Gourdon, Charles A. Thornton, Bé Wieringa, Derick G. Wansink	204
14	Myotonic Dystrophy: Therapeutic Strategies for the Future 2008 ·Neurotherapeutics ·Thurman M. Wheeler	36
15	Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1 2007 ·Neuromuscular Disorders ·Thurman M. Wheeler, (unknown), Charles A. Thornton	44
16	Myotonic dystrophy: RNA-mediated muscle disease 2007 ·Current Opinion in Neurology ·Thurman M. Wheeler, Charles A. Thornton	133
17	Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy 2007 ·Journal of Clinical Investigation ·Thurman M. Wheeler, John D. Lueck, Maurice S. Swanson, Robert T. Dirksen, Charles A. Thornton	195
18	Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy 2006 ·Proceedings of the National Academy of Sciences ·Rahul Kanadia, Jihae Shin, Yuan Yuan, Stuart G. Beattie, Thurman M. Wheeler, Charles A. Thornton, Maurice S. Swanson	274
19	Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration 2005 ·Proceedings of the National Academy of Sciences ·Carmen Bertoni, (unknown), Thurman M. Wheeler, Yining Li, Eric C. Olivares, Michèle P. Calos, Thomas A. Rando	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact